A Lagos-based fertility centre, FertProMax Fertility Clinic, is positioning itself to reshape Nigeria’s fast-growing in-vitro fertilisation (IVF) market by combining advanced medical technology with a strong focus on ethical reproductive care.
- +FertProMax bets on technology, ethics to disrupt Nigeria’s IVF market
Speaking during a media tour of the facility, Olajide Wilson, chief medical director, said the clinic’s strategy is built on precision medicine, transparency, and patient-centred services in a sector often criticised for uneven standards and limited regulation.
Speaking during a media tour of the facility, Olajide Wilson, chief medical director, said the clinic’s strategy is built on precision medicine, transparency, and patient-centred services in a sector often criticised for uneven standards and limited regulation.
“We are not just offering fertility treatment; we are building a system that prioritises clinical excellence, ethical integrity, and the overall well-being of patients,” Wilson said.
Nigeria’s fertility industry has expanded rapidly in recent years, driven by rising infertility rates, delayed parenthood, and growing awareness of assisted reproductive technologies. However, the sector still faces challenges around affordability, quality control, and ethical concerns, particularly in areas such as surrogacy and donor programmes.
FertProMax is seeking to differentiate itself by investing in advanced reproductive infrastructure, including modern IVF laboratories, cryopreservation systems for eggs, sperm, and embryos, and specialised diagnostic tools. The clinic also offers non-invasive prenatal testing, early pregnancy scans, and detailed reproductive monitoring.
A key part of its model is its dual role as both a primary fertility provider and a secondary support hub for other clinics. By opening its laboratory and technical capabilities to external practitioners, FertProMax is introducing a shared-services approach that could improve access to high-end fertility infrastructure across the country.
“This is about raising the standard of care, not just for our patients but across the ecosystem,” Wilson said.
Ethics is another pillar of the clinic’s positioning. The centre says its surrogacy programmes are structured with strict screening processes and legal oversight, an area where Nigeria lacks comprehensive regulation. Its sperm and egg donation systems are also built on screened donor databases and controlled selection processes to ensure safety and transparency.
Industry observers say this focus could become a competitive advantage as patients grow more conscious of the medical and legal risks associated with fertility treatments.
FertProMax is also highlighting its performance metrics as part of its market push. The clinic reports over 70 percent pregnancy and live birth success rates in surrogacy cases, more than 60 percent success using donor eggs, and above 55 percent live birth rates with patients’ own eggs.
While such figures are difficult to independently verify across the industry, they underscore the increasing competition among private fertility providers to demonstrate measurable outcomes and attract both local and international clients.
Beyond treatment, the clinic is promoting early fertility testing, including hormonal profiling, semen analysis, and ovarian reserve assessments. This preventive approach targets young couples and intending partners, encouraging earlier awareness of reproductive health challenges.
This shift could gradually change how Nigerians approach fertility, moving from late-stage intervention to proactive planning.
Still, affordability remains a key barrier. IVF procedures in Nigeria are largely funded out-of-pocket, limiting access for many families. As more clinics enter the market, pressure is expected to grow for pricing innovations, insurance integration, and broader policy support.
For now, FertProMax is betting that its combination of technology, ethical safeguards, and shared infrastructure will set it apart in an increasingly crowded field.
“Our vision is to become a leading fertility centre in Africa. But more importantly, we want to build trust in a space where trust is everything,” Wilson said.
As Nigeria’s reproductive health market evolves, clinics that can balance innovation with accountability may define the future of fertility care in the country.
